NSAID-Associated Gastrointestinal Bleeding Risk Factors and Prevention

Advanced age increases the risk of GI bleeding linearly at approximately 4% per year, according to the American Gastroenterological Association 1, 2
A history of peptic ulcer disease or prior NSAID GI complications increases the risk of GI bleeding 2-4 fold, as reported by the American Gastroenterological Association 3

Concomitant use of corticosteroids or anticoagulants increases the risk of GI bleeding, as noted by the American Gastroenterological Association 3
Concurrent use of multiple NSAIDs substantially increases the risk of GI bleeding, according to the American Gastroenterological Association 3
Concurrent use with aspirin increases the risk of GI bleeding 10-fold compared to non-NSAID users, as reported by the American Gastroenterological Association 3

Prevention and Management

Using the lowest effective dose of NSAIDs possible can minimize GI bleeding risk, as recommended by the American Gastroenterological Association 2
Using NSAIDs for the shortest duration necessary can minimize GI bleeding risk, according to the American Gastroenterological Association 2
Consideration of gastroprotection with proton pump inhibitors (PPIs) or misoprostol in high-risk patients can reduce GI bleeding risk, as recommended by the American Gastroenterological Association 2
Avoiding concurrent use of multiple NSAIDs can minimize GI bleeding risk, according to the American Gastroenterological Association 3
Being cautious with concurrent use of anticoagulants, which increases bleeding risk 5-6 times, is advised by the American Academy of Family Physicians 4

For patients requiring cardiovascular protection, ibuprofen may interfere with aspirin's cardioprotective effects, as noted by the American Gastroenterological Association 2
Celecoxib (COX-2 inhibitor) may have a lower GI risk than traditional NSAIDs but carries cardiovascular concerns, according to the American Academy of Family Physicians 4
The one-year risk of serious GI bleeding from chronic NSAID use ranges from 1 in 2,100 adults younger than 45 to 1 in 110 adults older than 75, as reported by the American Academy of Family Physicians 4
Even with gastroprotection, the risk of GI bleeding is reduced but not eliminated, according to the American Gastroenterological Association 2